CD8A and melanoma: Particularly, the number of CD8 T-cells, which is correlated with good clinical response to immunotherapy, is significantly lower in “non-immunogenic” cancers, such as pancreatic cancer, compared with “immunogenic” cancers, such as melanoma [43].